OGENORAGENICS INC

NYSE oragenics.com


$ 2.35 $ 0.69 (42.07 %)    

Friday, 17-May-2024 15:59:31 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 2.33
$ 1.69
$ 0.00 x 0
$ 2.35 x 250
$ 1.69 - $ 2.35
$ 1.00 - $ 7.74
534,458
na
8.15M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 04-17-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-03-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-04-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-03-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oragenics-partners-with-avance-clinical-for-phase-ii-concussion-trial-in-australia

Oragenics, Inc. (NYSE:OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today an...

 oragenics-inc-files-10k-and-provides-company-update

Oragenics, Inc. (the "Company") (NYSE:OGEN), a company focused on developing unique, intranasal pharmaceuticals for the...

 sp-500-edges-lower-adt-posts-upbeat-earnings

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow t...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 nasdaq-down-50-points-us-crude-stocks-rise-by-42m-barrels

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow trad...

 dow-dips-200-points-tjx-posts-upbeat-sales

U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market o...

 why-beyond-meat-shares-are-trading-higher-by-around-56-here-are-20-stocks-moving-premarket

Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-e...

 reported-earlier-oragenics-prices-public-offering-14m-common-shares-at-150share-for-gross-proceeds-of-21m

The Company intends to use the net proceeds from the offering to fund the continued development of ONP-002, which is a unique n...

 oragenics--chief-executive-officer-kimberly-murphy-enter-mutually-agreeable-separation-agreement

Murphy will, however, continue to serve as a member of the Company's board of directors. The Board will provide direction t...

 oragenics-inc-announces-expiration-of-its-investment-banking-engagement-agreement

Oragenics, Inc. (NYSE:OGEN), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment ...

 oragenics-prepares-phase-ii-clinical-trials-to-treat-concussion

Oragenics' lead drug candidate, ONP-002, is a new chemical entity (NCE) designed to target the brain through self-propelled...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION